Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,802 | 101,537 | 10,089 | 14,450 | 21,677 |
| TOTAL | $86,071 | $102,699 | $11,039 | $16,047 | $22,971 |
| Non-Current Assets | |||||
| PPE Net | 15 | 10 | 13 | 16 | 18 |
| Other Non-Current Assets | 244 | 0 | 0 | 0 | 0 |
| TOTAL | $259 | $10 | $13 | $16 | $18 |
| Total Assets | $86,330 | $102,709 | $11,052 | $16,063 | $22,989 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,029 | 612 | 2,045 | 2,383 | 1,828 |
| Accrued Expenses | 1,199 | 993 | 563 | 1,809 | 2,776 |
| TOTAL | $2,332 | $1,604 | $2,608 | $4,192 | $4,604 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 140 | 0 | 0 | 0 | 0 |
| TOTAL | $140 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,472 | $1,604 | $2,608 | $4,192 | $4,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,998 | 74,998 | 74,998 | 15,966 | 15,966 |
| Common Shares | 75 | 75 | 16 | 16 | 16 |
| Retained earnings | -91,437 | -73,977 | -71,722 | -68,055 | -61,285 |
| TOTAL | $83,858 | $101,105 | $8,443 | $11,871 | $18,385 |
| Total Liabilities And Equity | $86,330 | $102,709 | $11,052 | $16,063 | $22,989 |